The fight against tuberculosis is no longer just about better medicines or advanced diagnostics, rather, it is increasingly about speed
India strengthening of healthcare quality and innovation has received a major boost with a new collaboration between the central and state governments
The new regulatory move on brand name extension marks a significant step strengthening drug safety and reducing patient confusion in Indian pharma
India’s healthcare system is set for a major boost through medical insurance expansion. The government is considering doubling coverage under Ayushman Bharat
The Alzheimer's drug market is witnessing a significant strategic shift as Eisai and Biogen strengthen their competitive position. AS the new FDA approval allows at-home initiation of their therapy
With the emergence of new risks in the routine and complex surgical procedures, the threat of antibiotic resistance is increasingly attracting public awareness
The Data Protection debate has returned to the spotlight as global pharmaceutical companies renew their demand for stronger regulatory safeguards in India.
The Drug manufacturers sector could see a major regulatory change in the United States. The US FDA has proposed a new rule to simplify registration for certain companies using distributed manufacturing models.
India's Drug Deal Reform is set to tighten the country's public drug procurement system. The move aims to stop companies with canceled manufacturing licenses from securing government contracts. Officials believe the Drug Deal Reform will close...
Indian institutes and regulatory bodies are effectively taking steps in dengue preparedness and medical solutions for the issue
, CDSCO.jpg)